# HANDOFF

## Repository state (as of this session)

- Working tree has uncommitted changes (2 files: walk_forward.py + test_walk_forward.py). No commits made this session.
- Test suite: **277/277 passing** (`python3 -m pytest skills/quantitative-backtesting/tests/ -q`), up from 275 (2 new tests added).
- Standalone runner `python3 skills/quantitative-backtesting/tests/test_walk_forward.py`: **81/81 passed** (was 79).
- Root end-to-end script `verify_end_to_end.py`: **passes, exit 0**.

## What changed this session

### Completed the prior HANDOFF's next task: Deflated Sharpe p-value parity across the four analysis paths

The prior handoff asked to empirically verify DSR p-value parity across `walk_forward_analysis`, `cpcv_analysis`, `out_of_sample_validation`, and `run_monte_carlo --n-trials` on the same grid and data. Exploration (see below) showed `n_trials` was already reconciled across paths, but the **SR\* estimator was not** — `out_of_sample_validation` passed `trial_sharpes=None`, so its aggregate DSR used the i.i.d.-normal null approximation while `walk_forward_analysis`/`cpcv_analysis` used the pooled cross-sectional dispersion of trial Sharpes. Same `n_trials`, different SR\* → non-comparable p-values.

**Fix in `skills/quantitative-backtesting/scripts/walk_forward.py` (`out_of_sample_validation`, walk_forward.py:2115-2156):**
- `out_of_sample_validation` now pools the validation-phase trial Sharpes across periods/folds (`pooled_trial_sharpes`) and forwards them to `deflated_sharpe_ratio(..., trial_sharpes=pooled_trial_sharpes if pooled_trial_sharpes else None)`.
- Backward compatible: when a period/fold has no recorded trial Sharpes (validation ran without `apply_deflation`, or every combo was skipped), it still falls back to the full grid size for that period/fold and the i.i.d.-normal null (`trial_sharpes=None`), exactly as before.
- `deflated_sharpe_ratio` was **not** changed.

**Observed effect on the canonical 9-combo grid / 1200-period data (seed 11):**
- `n_trials`: walk_forward=61, cpcv=13, oos=61, param_optimization=9 (all match their counting bases).
- OOS aggregate p-value moved 0.999699 → 0.966322 (DSR 0.000301 → 0.033678), now on the same SR* estimator basis as walk-forward (p=0.991758). More informative, still conservative (OOS p ≤ walk-forward p).

**Tests added in `skills/quantitative-backtesting/tests/test_walk_forward.py`:**
- `test_out_of_sample_validation_uses_pooled_trial_sharpes_for_sr_star` — OOS aggregate must use pooled trial Sharpes (p < 0.999, and p ≤ walk-forward p on the same grid).
- `test_deflated_sharpe_parity_across_all_four_analysis_paths` — runs all four paths on the same grid/data and asserts: n_trials parity where counting bases agree (oos==wf, param_opt==full grid), SR* estimator parity (oos p ≤ wf p), and DSR/p_value in [0,1] with n_trials ≥ 1.
- Both registered in `main()`'s test list.

## Verified finding: n_trials accounting is already consistent across paths

Confirmed empirically (not just by reading code) on the same 9-combo grid / 1200-period data:
- `walk_forward_analysis` aggregate n_trials = 61 = sum of evaluated finite-Sharpe combos across periods.
- `cpcv_analysis` aggregate n_trials = 13 = sum across folds.
- `out_of_sample_validation` aggregate n_trials = 61 = same walk-forward selection on the train slice (matches walk_forward_analysis).
- `parameter_optimization` per-combo n_trials = 9 = full evaluated grid (one traversal).
- `run_monte_carlo --n-trials` uses `len(opt_results)` = 9 (reconciled, already done in a prior session).

So the remaining inconsistency was only the SR* estimator, now fixed.

## What remains unresolved

- `cpcv_analysis` n_trials (13) differs from walk-forward (61) because CPCV uses fewer folds/periods on the same train slice — this is correct behavior (different cross-validation schemes evaluate different numbers of combos), not a bug. No action needed.
- Reconciling the per-combo DSR in `parameter_optimization` (n_trials=9, one traversal) with the cross-period aggregates (61) would require a schema change exposing per-period trial counts; out of scope, and the current behavior is the standard per-combo correction.

## Next task (bounded, high-value)

The four-path DSR parity work is complete and verified. Candidate follow-ups, pick one:
1. **Robustness sweep parity**: verify the same SR*/n_trials parity holds for the cost sweeps (`--impact-coefficients`, `--borrow-costs`, `--funding-costs`) across walk-forward/cpcv/oos/monte-carlo sweep artifacts, where each coefficient re-runs the pipeline.
2. **Degenerate/constant-return DSR consistency**: `deflated_sharpe_ratio` emits DSR=0/p=1 for zero-variance returns; verify all four paths emit identical degenerate dicts (currently OOS uses `len(oos_returns) > 1` guard, monte-carlo uses `len(returns.dropna()) >= 2`).
3. **Document the DSR methodology** in `skills/quantitative-backtesting/SKILL.md` or a references file, since the parity invariant is now executable-guarded but not yet written down for researchers.

(End of file)